Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA
, Yexiao Cheng1
, Hangyu Zhou, Lulan Wang, Roberto Hurtado Fiel, Yehudah Gruenstein, Jean Jingzi Luo, Vishnu Singh, Eric Konadu, Keither James, Calvin Lui, Pengcheng Gao, Carl Urban, Nishant Prasad, Sorana Segal-Maurer, Esther Wurzberger, Genhong Cheng
, Aiping Wu
, and William Harry Rodgers
Author affiliations: NewYork-Presbyterian Queens Hospital, Flushing, New York, USA (D. Liu, J.J. Luo, V. Singh, E. Konadu, K. James, C. Lui, P. Gao, C. Urban, N. Prasad, S. Segal-Maurer, W.H. Rodgers);; Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China (Y. Cheng, H. Zhou, A. Wu); Suzhou Institute of Systems Medicine, Suzhou, China (Y. Cheng, H. Zhou, A. Wu);; University of California, Los Angeles, California, USA (L. Wang, G. Cheng); Kaiser Permanente Health, North Valley, California, USA (R.H. Fiel);; LabQ Diagnostics, Brooklyn, New York, USA (Y. Gruenstein, E. Wurzberger); Weill Cornell Medical College, New York (J.J. Luo, C. Urban, N. Prasad, S. Segal-Maurer, W.H. Rodgers)
Figure 4. Phylogeny of 392 SARS-CoV-2 Omicron variant virus isolates from New York, New York, USA, November 25–December 11, 2021. Colored dots represent isolates from this study by clade. Substitution locations are indicated.
Page created: January 11, 2023
Page updated: January 21, 2023
Page reviewed: January 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.